Revision as of 07:32, 3 September 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit | Latest revision as of 23:46, 21 April 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers174,388 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper | ||
(10 intermediate revisions by 8 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} | |||
{{Drugbox | {{Drugbox | ||
| verifiedrevid = |
| verifiedrevid = 428764846 | ||
| IUPAC_name = | | IUPAC_name = | ||
| image = | | image = | ||
<!--Clinical data--> | <!--Clinical data--> | ||
| tradename = | | tradename = Basaljel | ||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | ||
| pregnancy_US = <!-- A / B / C / D / X --> | | pregnancy_US = <!-- A / B / C / D / X --> | ||
Line 24: | Line 25: | ||
<!--Identifiers--> | <!--Identifiers--> | ||
| CAS_number = | | CAS_number = 41342-54-5 | ||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 6931E8LH07 | |||
| ATC_prefix = A02 | | ATC_prefix = A02 | ||
| ATC_suffix = AB04 | | ATC_suffix = AB04 | ||
| PubChem = | | PubChem = | ||
| DrugBank = | | DrugBank = | ||
| ChemSpiderID = 32698025 | |||
<!--Chemical data--> | <!--Chemical data--> | ||
| chemical_formula = | | chemical_formula = (HO)<sub>2</sub>Al(CO<sub>3</sub>)Na·nH<sub>2</sub>O | ||
| molecular_weight = | | molecular_weight = | ||
| smiles = C(=O)().O.... | |||
| StdInChI = 1S/CH2O3.Al.Na.3H2O/c2-1(3)4;;;;;/h(H2,2,3,4);;;3*1H2/q;+3;+1;;;/p-4 | |||
| StdInChIKey = YJTPLMXDQANDKS-UHFFFAOYSA-J | |||
}} | }} | ||
'''Dihydroxialumini sodium carbonate''' is an ]. | |||
'''Carbaldrate''' ('''dihydroxyaluminum sodium carbonate''') is an ].<ref name="pmid10752672">{{cite journal |vauthors=Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M |title=Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements |journal=Pharmacol. Toxicol. |volume=86 |issue=3 |pages=135–9 |date=March 2000 |pmid=10752672 |doi= 10.1034/j.1600-0773.2000.d01-25.x}}</ref><ref>{{cite web | url = https://www.drugs.com/inactive/dihydroxyaluminum-sodium-carbonate-433.html | title = Dihydroxyaluminum Sodium Carbonate | publisher = ]}}</ref> | |||
==References== | ==References== |
Latest revision as of 23:46, 21 April 2023
Chemical compound Pharmaceutical compoundClinical data | |
---|---|
Trade names | Basaljel |
ATC code | |
Identifiers | |
CAS Number | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | (HO)2Al(CO3)Na·nH2O |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Carbaldrate (dihydroxyaluminum sodium carbonate) is an antacid.
References
- Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M (March 2000). "Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements". Pharmacol. Toxicol. 86 (3): 135–9. doi:10.1034/j.1600-0773.2000.d01-25.x. PMID 10752672.
- "Dihydroxyaluminum Sodium Carbonate". drugs.com.
Drugs for acid related disorders: Antacids (A02A) | |
---|---|
Magnesium (increases motility) | |
Aluminium (decreases motility) | |
Calcium | |
Sodium | |
Combinations and complexes of aluminium, calcium and magnesium |
This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |